Insider · CIK 0001253820
Paul Kim
Files at XGN (EXAGEN INC.), FLGT (Fulgent Genetics, Inc.). First filing Mar 5, 2025, latest Mar 5, 2025.
Paul Kim files SEC Form 4 as CFO and director at FLGT (Fulgent Genetics, Inc.), and also at XGN (EXAGEN INC.). Since Mar 5, 2025, Paul Kim has reported 1 open-market buy worth $1.6M and 0 open-market sells worth $0, the latest filed on Mar 5, 2025.
A track record needs three past buys with six months of prices behind them; Paul Kim has 0, so none is measured yet.
The newest scored trade: bought $1.6M of FLGT on Mar 5, 2025, filed Mar 5, 2025, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FLGT: Fulgent Genetics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | FLGTbuy Fulgent Genetics, Inc. | $1.6M 100,000 shares | +40% | - |
Transactions
Every row this insider has filed, 48 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,087 | $19.59 | $41k | 356,543 | 40 d ago |
| Aug 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,168 | $19.81 | $23k | 358,630 | Aug 28, 2026 |
| Jun 9, 2026 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +37,500 | $0.00 | $0 | 46,500 | Aug 19, 2026 |
| Jul 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,747 | $19.67 | $54k | 359,798 | Jul 28, 2026 |
| Jun 1, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,087 | $18.09 | $38k | 362,545 | Jun 3, 2026 |
| May 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,168 | $17.67 | $21k | 364,632 | May 28, 2026 |
| Apr 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,747 | $16.31 | $45k | 365,800 | Apr 28, 2026 |
| Feb 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,168 | $24.76 | $29k | 378,027 | Mar 2, 2026 |
| Mar 1, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,133 | $15.33 | $17k | 376,894 | Mar 2, 2026 |
| Mar 1, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -8,347 | $15.33 | $128k | 368,547 | Mar 2, 2026 |
| Feb 23, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -661 | $23.01 | $15k | 327,485 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +5,721 | $0.00 | $0 | 333,206 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +14,926 | $0.00 | $0 | 348,132 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +26,673 | $0.00 | $0 | 374,805 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -3,241 | $23.09 | $75k | 371,564 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -8,456 | $23.09 | $195k | 363,108 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -15,095 | $23.09 | $349k | 348,013 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +31,182 | $0.00 | $0 | 379,195 | Feb 25, 2026 |
| Jan 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -3,004 | $27.53 | $83k | 328,146 | Jan 28, 2026 |
| Dec 1, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,131 | $28.52 | $32k | 331,150 | Dec 3, 2025 |
| Nov 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,166 | $30.15 | $35k | 332,281 | Dec 1, 2025 |
| Nov 23, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -671 | $30.00 | $20k | 333,447 | Nov 25, 2025 |
| Oct 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,743 | $23.74 | $65k | 334,118 | Oct 28, 2025 |
| Sep 1, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,131 | $22.17 | $25k | 336,861 | Sep 3, 2025 |
| Aug 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,166 | $21.47 | $25k | 337,992 | Aug 28, 2025 |
| Aug 23, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -670 | $21.77 | $15k | 339,158 | Aug 26, 2025 |
| Jul 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,743 | $18.37 | $50k | 339,828 | Jul 29, 2025 |
| Jun 10, 2025 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +9,000 | $0.00 | $0 | 18,000 | Jun 12, 2025 |
| Jun 10, 2025 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +9,000 | $0.00 | $0 | 9,000 | Jun 12, 2025 |
| Jun 1, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,131 | $20.72 | $23k | 342,571 | Jun 3, 2025 |
| May 23, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -671 | $20.31 | $14k | 344,868 | May 28, 2025 |
| May 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,166 | $20.31 | $24k | 343,702 | May 28, 2025 |
| Apr 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,743 | $18.88 | $52k | 345,539 | Apr 29, 2025 |
| Mar 5, 2025 | FLGT Fulgent Genetics, Inc. | POpen-market purchase Common Stock | +100,000 | $15.96 | $1.6M | 348,282 | Mar 5, 2025 |
| Mar 1, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,556 | $15.45 | $24k | 248,282 | Mar 4, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +3,384 | $0.00 | $0 | 204,172 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +5,346 | $0.00 | $0 | 209,518 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +13,949 | $0.00 | $0 | 223,467 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,914 | $16.29 | $31k | 221,553 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -3,024 | $16.29 | $49k | 218,529 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -8,228 | $16.29 | $134k | 210,301 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +44,199 | $0.00 | $0 | 254,500 | Feb 27, 2025 |
| Feb 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,662 | $16.24 | $76k | 249,838 | Feb 27, 2025 |
| Feb 23, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -733 | $16.46 | $12k | 200,788 | Feb 25, 2025 |
| Jan 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -3,000 | $17.21 | $52k | 201,521 | Jan 28, 2025 |
| Dec 1, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,553 | $18.30 | $28k | 204,521 | Dec 4, 2024 |
| Nov 25, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -669 | $17.87 | $12k | 206,074 | Nov 27, 2024 |
| Oct 26, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,738 | $19.42 | $53k | 206,743 | Oct 29, 2024 |
Questions about Paul Kim
Answered from the filings on this page, as of the latest one.
Is Paul Kim buying or selling?
Not in the last 12 months. Paul Kim's latest open-market trade on SEC Form 4 was bought $1.6M of FLGT on Mar 5, 2025.
How did Paul Kim's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Kim has 0.
Where does Paul Kim file Form 4?
Paul Kim has filed Form 4 at FLGT (Fulgent Genetics, Inc.) as CFO and Treasurer; XGN (EXAGEN INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.